Cited by 172Pneumocystis jirovecii pneumonia detection and treatmentPneumonia and Respiratory InfectionsHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.

Kazanjian, Powel, Locke, Amy B., Hossler, Paul A., Lane, Brian R., Bartlett, Marilyn S., Smith, James W., Cannon, Mark, Meshnick, Steven R.·1998·AIDS

DOI 10.1097/00002030-199808000-00009

Open this paper in CoChat — free account

Abstract

BACKGROUND: Failures of prophylaxis against Pneumocystis carinii pneumonia (PCP) in AIDS patients do occur, but no evidence for drug resistance has yet been presented. OBJECTIVE: To determine whether mutations in the sulfa and sulfone drug target are associated with failure of prophylaxis using a sulfa-containing agent. METHODS: Portions of the gene for P. carinii dihydropteroate synthase (DHPS), the sulfa and sulfone target, from 27 patients (20 of whom had AIDS) diagnosed with PCP between 1976 and 1997 were amplified using polymerase chain reaction and sequenced. Seven of the 27 patients (all of whom had AIDS) were receiving sulfa or sulfone drugs as prophylaxis for PCP. RESULTS: Mutations were found at only two amino-acid positions and were significantly more common in patients who received sulfa/sulfone prophylaxis. Mutations were observed in five (71%) out of seven isolates from AIDS patients receiving sulfa/sulfone as prophylaxis compared with only two (15%) out of 13 specimens from AIDS patients who did not (P = 0.022). No mutations were seen in isolates from seven non-HIV-infected patients, none of whom were on prophylaxis. Mutations were only observed in specimens obtained in 1995-1997. CONCLUSIONS: Mutations in two amino-acid positions were significantly more common in AIDS patients with PCP who failed sulfa/sulfone prophylaxis. These amino acids appeared to be directly involved in both substrate and sulfa binding, based on homology to the Escherichia coli DHPS crystal structure. Thus, the results were consistent with the possibility that mutations in the P. carinii DHPS are responsible for some of the failures of sulfa/sulfone prophylaxis in AIDS patients.

Integrity signals

Registry

Crossref · 10.1097/00002030-199808000-00009

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Pulmonary Complications of the Acquired Immunodeficiency Syndrome
Murray, J. F., Felton, C. P., Garay, S. M., Gottlieb, M. S., Hopewell, P. C., Stover, D. E., & Teirstein, A. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406213102529 · Cited by 683
Sequence Variation of the Hydroxymethyldihydropterin Pyrophosphokinase: Dihydropteroate Synthase Gene in Lines of the Human Malaria Parasite, Plasmodium falciparum , with Differing Resistance to Sulfadoxine
Brooks, D. R., Wang, P., Read, M., Watkins, W. M., Sims, P. F. G., & Hyde, J. E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00397.x · Cited by 369
A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection
Bozzette, S. A., Finkelstein, D. M., Spector, S. A., Frame, P. T., Powderly, W. G., He, W., Phillips, L., Craven, D. E., van der Horst, C., & Feinberg, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321101 · Cited by 329
Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase
Achari, A., Somers, D. 0., Champness, J. N., Bryant, P. K., Rosemond, J., & STAMMERS, D. K. (1997) · Nature Structural Biology · doi:10.1038/nsb0697-490 · Cited by 297
A Meta-analysis of the Relative Efficacy and Toxicity of Pneumocystis carinii Prophylactic Regimens
Ioannidis, J. P. A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440020081010 · Cited by 197
Genetic Variation among Pneumocystis carinii hominis Isolates in Recurrent Pneumocystosis
Keely, S. P., Stringer, J. R., Baughman, R. P., Linke, M. J., Walzer, P. D., & Smulian, A. G. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.2.595 · Cited by 183
Dihydropteroate synthase polymorphisms in Pneumocystis carinii.
Lane, B. R., Ast, J. C., Hossler, P. A., Mindell, D. P., Bartlett, M. S., Smith, J. W., & Meshnick, S. R. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.2.482 · Cited by 176
Self-citation
Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme
López, P., Espinosa, M., Greenberg, B., & Lacks, S. A. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.9.4320-4326.1987 · Cited by 132
Pneumocystis carinii: what is it, exactly?
Stringer, J. R. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.489 · Cited by 120
Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species
Fermér, C., Kristiansen, B., Sköld, O., & Swedberg, G. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.16.4669-4675.1995 · Cited by 94

Show all 20 references

Research works printed but not linked: 2

1992, MMWR, 41, 1
Beard, 1995, Emerg Infect Dis, 2, 147

Sorted by citations

Items 101–172 of 172

Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients—preliminary report
Szydłowicz, M., Jakuszko, K. J., Szymczak, A., Piesiak, P., Kowal, A., Kopacz, Ż., Wesołowska, M., Lobo, M., Matos, O., Hendrich, A. B., et al. (2018) · Parasitology Research · doi:10.1007/s00436-018-6131-0 · Cited by 15
Drug resistance in Pneumocystis carinii: an emerging problem
Walker, D. J., & Meshnick, S. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80040-x · Cited by 15
Self-citation
Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations and Human Immunodeficiency Virus‐Associated Pneumocystis Pneumonia
Huang, L., Welsh, D. A., Miller, R. F., Beard, C. B., Lawrence, G. G., Fox, M., Swartzman, A., Bensley, M. R., CARBONNET, D., Davis, J. L., et al. (2006) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2006.00195.x · Cited by 14
Management of community-acquired pneumonia in HIV-infected children
Gray, D. M., & Zar, H. J. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.14 · Cited by 14
Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates.
Demanche, C., Guillot, J., Berthelemy, M., Petit, T., Roux, P., & Wakefield, A. E. (2002) · Medical Mycology · doi:10.1080/714031111 · Cited by 13
Study of dihydropteroate synthase (DHPS) gene mutations among isolates of Pneumocystis jiroveci.
Tyagi, A. K., Mirdha, B. R., Guleria, R., Mohan, A., Luthra, K., & Singh, U. B. (2008) · PubMed · Cited by 13
Dihydropteroate synthase gene mutation rates in Pneumocystis jirovecii strains obtained from Iranian HIV-positive and non-HIV-positive patients
Sheikholeslami, F. M., Sadraei, J., Farnia, P., Moghadam, M. F., & Emadi-Kochak, H. (2015) · Medical Mycology · doi:10.1093/mmy/myu095 · Cited by 13
Editorial Response: Prophylaxis for Pneumocystis carinii Pneumonia in Solid Organ Transplant Recipients‐As Long as the Pros Outweigh the Cons
Arend, S. M., & Wout, J. W. V. (1999) · Clinical Infectious Diseases · doi:10.1086/515127 · Cited by 13
Pneumocystis Dihydropteroate Synthase Mutations in Patients with Pneumocystis Pneumonia Who Are Newly Diagnosed with HIV Infection
CROTHERS, K., HUANG, L., MORRIS, A., FOX, M., GRONER, G., TURNER, J. R., MERRIFIELD, C., EISER, S., FRIEDLY, J., GRAVARI, E., et al. (2003) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2003.tb00648.x · Cited by 12
Cloning of the Pneumocystis jirovecii trifunctional FAS gene and complementation of its DHPS activity in Escherichia coli
Iliades, P., Walker, D. J., Castelli, L. A., Satchell, J. F., Meshnick, S. R., & Macreadie, I. G. (2004) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2004.08.006 · Cited by 12
Self-citation
Opportunistic Infections (OIs) as Emerging Infectious Diseases: Challenges Posed by OIs in the 1990s and Beyond
Kaplan, J. E., Hanson, D. L., Jones, J. L., Beard, C. B., Juranek, D. D., & Dykewicz, C. A. (2014) · ASM Press eBooks · doi:10.1128/9781555816957.ch14 · Cited by 12
Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia
Long, Y., Zhang, C., Su, L., & Que, C. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2002 · Cited by 11
PCR‐RFLP Analysis of the DHPS gene for the Study of Resistance of Pneumocystis carinii to Sulpha Drugs in Patients with Co‐infection PCP/HIV
Costa, M. C., Helweg‐Larsen, J., Antunes, F., LUNGREN, B., Diogo, J., & Matos, O. (2001) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2001.tb00493.x · Cited by 11
Pneumocystis carinii.Dihydropteroate Synthase Mutations and Treatment with Sulfa or Sulfone Regimens: a Proposal for Standardized Definitions for Clinical Evaluation
HUANG, L., MORRIS, A. M., & BEARD, C. B. (2001) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2001.tb00510.x · Cited by 10
Dihydropteroate synthase gene mutations in Pneumocystis jiroveci strains isolated from immunocompromised patients
Jarboui, M. A., Sellami, A., Sellami, H., Cheikhrouhou, F., Makni, F., & Ayadi, M. A. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.02.001 · Cited by 10
Absence of dihydropteroate synthase gene mutations inPneumocystis jiroveciiisolated from Swedish patients
Beser, J., Dini, L., Botero-Kleiven, S., Krabbe, M., Lindh, J. G., & Hagblom, P. (2012) · Medical Mycology · doi:10.3109/13693786.2011.593051 · Cited by 10
Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia
Tyagi, A. K., Mirdha, B. R., Luthra, K., Guleria, R., Mohan, A., Singh, U. B., Samantaray, J. C., Dar, L., Iyer, V. K., & Chaudhry, R. (2010) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.914 · Cited by 10
Pneumocystis carinii pneumonia in patients with and without HIV infection
Santamauro, J. T., Aurora, R. N., & Stover, D. E. (2002) · Comprehensive Therapy · doi:10.1007/s12019-002-0047-3 · Cited by 10
Pneumocystis carinii Dihydropteroate Synthase Genotypes in HIV‐infected Persons Residing in San Francisco: Possible Implications for Disease Transmission
HUANG, L., FRIEDLY, J., MORRIS, A. M., CARTER, J. L., TURNER, J. R., MERRIFIELD, C., NAVIN, T. R., & BEARD, C. B. (2001) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2001.tb00487.x · Cited by 9
Pneumocystis jirovecii Dihydrofolate Reductase Polymorphisms Associated with Failure of Prophylaxis
Nahimana, A., Rabodonirina, M., Francioli, P. B., Billé, J., & Hauser, P. M. (2003) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2003.tb00673.x · Cited by 9
Distribution of DHPS Mutations Among ITS Subtypes of P. carinii f. sp. hominis
Meshnick, S. R., Hossler, P. A., Enger, K. S., Kazanjian, P. H., Rest, J. S., Mindell, D. P., Li, B., Lee, C., Nimri, L. F., Carter, J. L., et al. (2001) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2001.tb00481.x · Cited by 9
Self-citation
Molecular Characterization of Recombinant Pneumocystis carinii Topoisomerase I: Differential Interactions with Human Topoisomerase I Poisons and Pentamidine
Dross, R. V., & Sanders, M. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2145-2154.2002 · Cited by 9
Editorial Response: Do Bacterial Pneumonia and Pneumocystis carinii Pneumonia Accelerate Progression of Human Immunodeficiency Virus Disease?
Kaplan, J. E., Janoff, E. N., & Masur, H. (1999) · Clinical Infectious Diseases · doi:10.1086/598630 · Cited by 9
Absence of Pneumocystis dihydropteroate synthase mutants in Brittany, France
Gal, S. L., Robert-Gangneux, F., Perrot, M., Rouillé, A., Virmaux, M., Damiani, C., Totet, A., Gangneux, J., & Nevez, G. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.01.018 · Cited by 8
Laboratory diagnosis of Pneumocystis jirovecii pneumonia
Matos, O., & Esteves, F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804543-5.00013-0 · Cited by 8
Pneumocystis jirovecii and Pneumocystosis
Matos, O., Tomás, A. L., & Antunes, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-64113-3_7 · Cited by 8
Resistencia genotípica a sulfamidas en pacientes con neumonía por Pneumocystis jiroveci
Calderón, E. J., de la Horra, C., Montes‐Cano, M. A., RESPALDIZA, N., Martín‐Juan, J., & Varela, J. M. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)74328-6 · Cited by 8
Prevalence of dihydropteroate synthase mutations in Spanish patients with HIV-associated Pneumocystis pneumonia
Friaza, V., Montes‐Cano, M. A., RESPALDIZA, N., Morilla, R., Calderón, E. J., & de la Horra, C. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.01.015 · Cited by 8
Evaluation of the PneumoGenius® PCR assay for the diagnosis ofPneumocystispneumonia and the detection ofPneumocystisdihydropteroate synthase mutations in respiratory samples
Guegan, H., Roojee, M., Gal, S. L., Artus, M., Nevez, G., Gangneux, J., & Robert-Gangneux, F. (2023) · Medical Mycology · doi:10.1093/mmy/myad032 · Cited by 6
Development and emerging trends of drug resistance mutations in HIV: a bibliometric analysis based on CiteSpace
Chen, X., Chen, X., & Lai, Y. L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374582 · Cited by 6
Geographical Variation in the Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Mutations Within Western Europe
Rabodonirina, M., Nahimana, A., Weber, R. K., Francioli, P. B., Billé, J., & Hauser, P. M. (2006) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2006.00194.x · Cited by 6
Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia
Edge, M. D., & Rimland, D. (1999) · AIDS · doi:10.1097/00002030-199905280-00017 · Cited by 6
Analysis of random mutations in Salmonella Gallinarum dihydropteroate synthase conferring sulfonamide resistance
Duysak, T., Jeong, J., Kim, K., Kim, J., & Choy, H. E. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03696-5 · Cited by 5
Respiratory infections in immunocompromised patients
Barry, S. M., Lipman, M. C. I., Johnson, M. A., & Prentice, H. G. (1999) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-199905000-00008 · Cited by 5
Effective alternates to trimethoprim‐sulfamethoxazole as antimicrobial prophylaxis in stem cell recipients: Are there any?
Ramesh, M. S., & Chandrasekar, P. H. (2008) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2008.00987.x · Cited by 4
Échec de traitement d'une pneumocystose par le cotrimoxazole: rôle de la co-infection par le cytomégalovirus?
Scemama, J., Amathieu, R., Tual, L., Fessenmeyer, C., Stirnemann, J., & Dhonneur, G. (2007) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2007.02.020 · Cited by 4
Human Immunodeficiency Virus-Related Opportunistic Infections in the Era of Highly Active Antiretroviral Therapy
Masur, H. (2014) · ASM Press eBooks · doi:10.1128/9781555816971.ch12 · Cited by 4
Site‐Directed Mutagenesis of the Saccharomyces cerevisiae Dihydropteroate Synthase FOL1 Gene to Study Pneumocystis jirovecii Mutations in the Orthologue Gene FAS
Meneau, I., Sanglard, D., Billé, J., & Hauser, P. M. (2003) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2003.tb00671.x · Cited by 4
Protective effect of DNA vaccine with the gene encoding 55kDa antigen fragment against Pneumocystis carinii in mice
Duan, Y., LiangHeng, Y., Chen, J., Zhu, D., Wang, J., Feng, J., Qin, Y., & Zhu, Y. (2011) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(11)60102-8 · Cited by 3
Molecular Analysis of Dihydropteroate Synthase Gene Mutations in Pneumocystis jirovecii Isolates among Bulgarian Patients with Pneumocystis Pneumonia
Tsvetkova, N., Harizanov, R., Rainova, I., Ivanova, A., & Yancheva-Petrova, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316927 · Cited by 3
Pneumocystis : diagnostic biologique des infections à Pneumocystis jirovecii
Gal, S. L., Damiani, C., Totet, A., & Nevez, G. (2012) · EMC - Biologie Médicale · doi:10.1016/s2211-9698(12)53929-4 · Cited by 3
Is Pneumocystis carinii pneumonia after stem cell transplantations a contagious disease?
Resnick, I. B., Averbuch, D., Aker, M., & Engelhard, D. (2005) · Clinical Transplantation · doi:10.1111/j.1399-0012.2005.00346.x · Cited by 3
Épidémiologie moléculaire de la pneumocystose humaine
Roux, P., & Latouche, S. (1999) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(00)88282-7 · Cited by 3
Pneumocystosis
Decker, C. F., & Masur, H. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_26 · Cited by 2
Drug Resistance in Pneumocystis jirovecii
Helweg‐Larsen, J., Benfield, T., Kovacs, J. A., & Masur, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_22 · Cited by 2
A Case of Pneumonia Caused byPneumocystis jiroveciiResistant to Trimethoprim/Sulfamethoxazole in the Absence of Previous Drug Exposure
Ahn, A., Chang, J., Sung, H., & Kim, M. (2016) · Laboratory Medicine Online · doi:10.3343/lmo.2016.6.4.250 · Cited by 2
Dihydropteroate Synthase (DHPS) Gene Mutations in Human Pneumocystosis
Mirdha, B. R. (2021) · Journal of AIDS and HIV Treatment · doi:10.33696/aids.3.015 · Cited by 2
Extracellular vesicle-mediated delivery of genetic material for transformation and CRISPR/Cas9-based gene editing in Pneumocystis murina
Sayson, S. G., Ashbaugh, A., Bauer, L. C., & Smulian, A. G. (2025) · mBio · doi:10.1128/mbio.01825-25 · Cited by 1
Pulmonary Manifestations of HIV Disease
Muhwa, J. C. (2011) · InTech eBooks · doi:10.5772/22700 · Cited by 1
Human Immunodeficiency Virus Infection
George, M. P., & Morris, A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00141-5 · Cited by 1
AIDS in the Intensive Care Unit
Forrest, D. M., Zala, C., Harris, M., Phillips, P., Russell, J. A., & Montaner, J. S. G. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1679-8_9 · Cited by 1
Response to Dr. Friaza submission: “Prevalence of dihydropteroate synthase mutations in Spanish patients with HIV-associated Pneumocystis pneumonia”
Álvarez-Martínez, M. J., Camacho, A. M., Miró, J. M., Valls, M. E., & Meshnick, S. R. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.01.016 · Cited by 1
Self-citation
Approche moléculaire de la pneumocystose
Latouche, S., Santos, L. D., Lacube, P., BOLOGNINI, J., & Roux, P. (2000) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(00)80398-4 · Cited by 1
Pneumocystis — A Genus Long Known, But with Relationships Only Recently Appreciated
Stringer, J. R., & Walzer, P. D. (2004) · Springer eBooks · doi:10.1007/978-3-662-10380-7_9 · Cited by 1
Structural and Kinetics Studies of the Enzyme Dihydropteroate Synthase and the Implications for Antibiotic Resistance
Ayers, K. (2009) · doi:10.21007/etd.cghs.2009.0020 · Cited by 1
Pneumocystispneumonia
Cushion, M. T. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0164 · Cited by 1
Reply
Madhi, S. A., & Klugman, K. P. (2003) · Clinical Infectious Diseases · doi:10.1086/368215 · Cited by 1
Genetic investigations of pneumocystis jirovecii : detection, cotrimoxazole resistance and population structure
Robberts, F. J. L. (2005) · SUNScholar (Stellenbosch University) · Cited by 1
NEONATAL IMMUNE MODULATION TO IMPROVE PNEUMOCYSTIS CLEARANCE
Empey, K. M. (2007) · UKnowledge (University of Kentucky)
Characterisation ofPneumocystis jiroveciiDHPS genotypes using a simple, inexpensive restriction fragment length polymorphism analysis
Mogoye, B. K., du Plessis, D., Poonsamy, B., & Frean, J. (2015) · Southern African Journal of Infectious Diseases · doi:10.1080/23120053.2015.1054180
Mutations du gène codant la dihydroptéroate synthase (DHPS) et résistance aux traitements anti-Pneumocystis : mythe ou réalité ?
Morio, F. (2014) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2014.03.001
Management and Prevention of Opportunistic Infections in the HIV-Infected Patient
Purdy, B. D. (2000) · Journal of Pharmacy Practice · doi:10.1106/jdyc-jyvc-xjaa-lj1f
Caracterização de múltiplos polimorfismos de Pneumocystis Jirovecii por multiplex-PCR/Single base extension
Fernandes, C. B. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Prevalencia de mutaciones en el gen de la dihidropteroato sintetasa de Pneumocystis jiroveci en pacientes con sida en España
Álvarez, M. J., Miró, J. M., Moreno, A., & Meshnick, S. (2005) · Medicina Clínica · doi:10.1157/13070426
Self-citation
11 Molecular Epidemiology of Pneumocystis Outbreaks
Hauser, P. M., & Kovacs, J. A. (2013) · Springer eBooks · doi:10.1007/978-3-642-39432-4_11
Humoral Immunity to the Opportunistic Pathogen, Pneumocystis, in a Simian Model of HIV Infection.
Kling, H. M. (2010) · D-Scholarship@Pitt (University of Pittsburgh)
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1301 Sulphonamide Resistance in Neisseria meningitidis and Commensal Neisseria Species
Qvarnström, Y. (2003)
Drug Resistance in Pneumocystis jirovecii
Helweg‐Larsen, J., Benfield, T., Kovacs, J. A., & Masur, H. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-595-8_22
Pulmonary Complications of HIV Infection
Wagner, K. R., & Chaisson, R. E. (2004) · Elsevier eBooks · doi:10.1016/b978-012764051-8/50018-4
SPECTROPHTOTOMETRIC DETERMINATION OF PURE SULFAMETHOXAZOLE IN PHARMACEUTICAL PREPARATIONS BY OXIDATIVE COUPLING REACTION
noormansoor40@gmail.com, 1., & Allah1, N. M. G. (2021) · Iraqi Journal of Market Research and Consumer Protection · doi:10.28936/jmracpc13.1.2021.(7
Pathogenesis of Pneumocystis infection
Medrano, F. J., Delgado, J., & Calderón, E. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00096-4
Comprehensive analysis of the susceptibility of non-archetypal Brazilian strains of Toxoplasma gondii to sulfadiazine and pyrimethaminePreprint
da Cunha, G. M. R., Dantas-Vieira, G. C., Dias-Santos, A., Freire, L. D. O., Lopes, R. E. N., Bleicher, L., Berná, L., Francia, M. E., Vitor, R. D. A., & Martins-Duarte, É. S. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7301903

Authors: Kazanjian, P., Locke, A. B., Hossler, P. A., Lane, B. R., Bartlett, M. S., Smith, J. W., Cannon, M., & Meshnick, S. R.
Affiliations: University of Michigan (US)
Indiana University (US)
ORCID: Kazanjian, Powel
Locke, Amy B.
Lane, Brian R.
Smith, James W.
Venue: AIDS
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1998-05
Volume: 12
Issue: 8
Pages: 873-878
ISSN: 0269-9370 (ISSN-L)
DOI: 10.1097/00002030-199808000-00009
OpenAlex: W2027990333
Cited by: 171
References: 20
Citations by year: 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 3 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 5 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 6
FWCI: 12.18
Type: journal article
Language: en
Open access: closed
Locations: AIDS (publishedVersion)
PubMed (publishedVersion)
Funders: University of Michigan
National Institutes of Health (5r01ai031775-05)
National Institute of Allergy and Infectious Diseases (R01-AI 31775)
Topics: Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: Pneumocystis carinii, Pneumocystis carinii pneumonia, dihydropteroate synthase, dhps mutations, drug resistance, prophylaxis failure, amino acid substitutions
MeSH terms: Adolescent, Adult, Aged, Amino Acid Sequence, Anti-Infective Agents, Child, Dapsone, Dihydropteroate Synthase, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Mutation, Pneumocystis, Pneumonia, Pneumocystis, Trimethoprim, Sulfamethoxazole Drug Combination, Polymerase Chain Reaction, AIDS-Related Opportunistic Infections, Treatment Failure, Sequence Analysis, DNA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks